[Consequences of Helicobacter pylori infection on the incidence and treatment of gastro-duodenal ulcers in patients taking non-steroidal anti-inflammatory agents].
Lamarque
D
D
Service d'Hépatologie et de Gastroentérologie, Centre Hospitalier Universitaire Henri-Mondor, Créteil.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D000897:Anti-Ulcer Agents / Q000627:therapeutic use; D016481:Helicobacter Infections / Q000139:chemically induced* / Q000188:drug therapy*; D016480:Helicobacter pylori; D006801:Humans; D015994:Incidence; D010437:Peptic Ulcer / Q000139:chemically induced* / Q000188:drug therapy*
D000900:Anti-Bacterial Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D000897:Anti-Ulcer Agents